Atlas Trials

The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk

Clinical trial NCT05018520 · RECRUITING

Trial details

NCT number
NCT05018520
Sponsor
Ruijin Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2021-09-17
Primary completion
2028-06-30
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.